HeadlinesBriefing favicon HeadlinesBriefing

Sector Investment 24 Hours

×
9 articles summarized · Last updated: LATEST

Last updated: July 4, 2026, 2:31 AM ET

Infrastructure Investment

Conifer Infrastructure has closed its inaugural fund at $900 million, exceeding its target and deploying approximately $190 million across hydroelectric, biogas, and helium platforms. The fund aims for a net internal rate of return of 25%. Meanwhile, Seraya Partners is approaching the halfway mark for its $1.5 billion sophomore infrastructure fund, with a final close anticipated by the end of 2026. The European Bank for Reconstruction and Development (EBRD) is identifying infrastructure as a promising area for nature-based finance initiatives, signaling a growing trend in sustainable investment within the sector. Allianz Global Investors is also increasing its focus on infrastructure secondaries, reflecting a dynamic secondary market.

Energy & Infrastructure Exposure

Samsung Asset Management is boosting its infrastructure exposure, with a particular interest in energy-related opportunities and an expanded risk appetite. The Korean government’s investment manager is actively seeking new avenues for capital deployment within the energy infrastructure space. Separately, the European energy company Uniper is being viewed as a potential phoenix moment within the infrastructure funds sector, suggesting a turnaround or significant strategic shift.

Real Estate & Capital Markets

Aware Super has made its debut commitment to student housing, pledging €426 million to a venture that will also mark its first investment in German real estate. This move by the Australian superannuation fund expands its international property portfolio. In capital markets, Urban Partners, a manager focused on Northern Europe, has appointed a new lead for North American investor relations, aiming to deepen its relationships with US and Canadian investors.

Healthcare Dealmaking

Arlington Capital Partners has reached an agreement to sell Riverpoint Medical to Novanta. This transaction marks a significant divestiture for the private equity firm in the healthcare sector, as Novanta, a manufacturer of medical and advanced technology manufacturing solutions, prepares to integrate Riverpoint Medical into its operations.